Top Markets
#1 Bedrock Bedrock +24.46%
#2 iExec RLC iExec RLC +22.99%
#3 API3 API3 +21.64%
#4 CyberDEX CyberDEX +19.33%
#5 Radicle Radicle +19.03%
#6 Talus Network Talus Network +18.92%
#7 The Bitcoin Bull The Bitcoin Bull +16.86%
#8 Orca Orca +13.08%
#9 VeThor VeThor +12.76%
#10 Nockchain Nockchain +11.65%
Coin of the day
Bedrock Bedrock
설정
언어
한국어
통화
USD
테마
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
주식 순위 #28207
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
주가
$0.4
마지막 동기화: 2026-10-02
시가총액
$27.18M
변동 (1일)
-14.88%
변동 (1년)
8.11%
국가
US
거래 Cell Source, Inc. (CLCS)

카테고리

Healthcare
Cell Source, Inc. (CLCS)의 주가 이력
최고 종가: $0.43 (2026-10-01 기준)

최저 종가: $0.88 (2014-05-01 기준)
Cell Source, Inc.의 주가 이력 (2014 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 57.71%
2025 -22.76%
2024 28.36%
2023 -41.25%
2022 -46.94%
2021 9.84%
2020 34.16%
2019 39.21%
2018 131.41%
2017 -37.38%
2016 -65.99%
2015 149.25%
2014 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $503.48 24.96%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $201.85 632.93%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $125.69 -7.66%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $915.50 16.19%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $767.59 9.52%
CH